| Dr Harrison Bradford Hawley, MD | |
|
6761 Trailview Dr, Dayton, OH 45414-2165 | |
| (937) 898-2153 | |
| Not Available |
| Full Name | Dr Harrison Bradford Hawley |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Infectious Disease |
| Location | 6761 Trailview Dr, Dayton, Ohio |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1669895660 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RI0200X | Internal Medicine - Infectious Disease | 35.043706 (Ohio) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Harrison Bradford Hawley, MD 6761 Trailview Dr, Dayton, OH 45414-2165 Ph: (937) 898-2153 | Dr Harrison Bradford Hawley, MD 6761 Trailview Dr, Dayton, OH 45414-2165 Ph: (937) 898-2153 |
News Archive
University of Delaware scientists have invented a novel biomaterial with surprising antibacterial properties that can be injected as a low-viscosity gel into a wound where it rigidifies nearly on contact-opening the door to the possibility of delivering a targeted payload of cells and antibiotics to repair the damaged tissue.
EpiCept Corporation announced today that it has amended the Company's Loan and Security Agreement with MidCap Financial, LLC effective August 27, 2012.
"When blockbuster drugs lose their patent protection, state Medicaid programs can save millions of dollars by switching patients to cheaper, generic versions of the medications." But, while some states have policies to shift people quickly to generics, others require permission from patients. "A new study tracking these policies concludes that some states, including Massachusetts, are quicker than others to bring down the costs of prescription drugs once alternatives are available. The difference has implications for expanding Medicaid coverage to more people after the national health care overhaul takes effect" (Cooney, 7/8).
ImmunoGen, Inc., a biotechnology company that develops targeted anticancer products using its antibody expertise and Targeted Antibody Payload (TAP) technology, today announced that the US Food and Drug Administration (FDA) has granted orphan drug designation to its IMGN901 compound when used for the treatment of Merkel cell carcinoma (MCC). Through a separate process, the European Union (EU) Committee for Orphan Medicinal Products (COMP) concurrently also granted IMGN901 orphan medicinal product designation for the treatment of MCC.
› Verified 4 days ago
Abraham Wei, Infectious Disease Medicare: Medicare Enrolled Practice Location: 128 E Apple St, 2nd Floor, Dayton, OH 45409 Phone: 937-208-2004 Fax: 937-208-8828 | |
Ratnam A Oza, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 1100 S Main St, Ste. 203, Dayton, OH 45409 Phone: 937-222-0603 Fax: 937-222-7122 | |
Dr. Mohamed Elmouelhi, MD, PHD Infectious Disease Medicare: Not Enrolled in Medicare Practice Location: 4100 W.third St., Dayton Vamc (11c), Dayton, OH 45428 Phone: 937-268-6511 | |
Freesia Dhingra, M.D Infectious Disease Medicare: Medicare Enrolled Practice Location: 4100 W. Third St., Dayton, OH 45428 Phone: 937-268-6511 | |
James P Graham, M.D. Infectious Disease Medicare: Not Enrolled in Medicare Practice Location: 1520 S Main St, # 2, Dayton, OH 45409 Phone: 937-461-5815 Fax: 937-461-2896 | |
Ugochukwu Nwokoro, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 1735 Big Hill Rd, Dayton, OH 45439 Phone: 937-224-4325 Fax: 937-224-4327 | |
Dr. Howard M Gross, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 8881 N Main St, Dayton, OH 45415 Phone: 937-293-1622 Fax: 937-245-6308 |